Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Nature|March 19, 2010
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescenceHui-Kuan Lin, Zhenbang Chen, Guocan Wang, et al.
The Journal of Clinical Investigation|September 7, 2018
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapyPriyamvada Jayaprakash, Midan Ai, Arthur Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2024
Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarizationGuoyu Yu, Paul G Corn, Celia Sze Ling Mak, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironmentGuoyu Yu, Paul G Corn, Celia Sze Ling Mak, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
ARID1A deficiency unleashes centromeric RNA transcription to drive chromosomal instability and boosts PKMYT1 inhibitor efficacy via RNA sensingChengguo Li, Xueqian Cheng, Weizhen Liu, et al.
Nature|February 7, 2017
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancerDi Zhao, Xin Lu, Guocan Wang, et al.
Nature Genetics|June 4, 2013
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasionGuocan Wang, Andrea Lunardi, Jiangwen Zhang, et al.
Oncogene|September 2, 2021
P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasisMing Zhu, Ruiqing Peng, Xin Liang, et al.
Nature Genetics|June 4, 2013
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.
Nature Genetics|September 5, 2020
Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.
Pageof 5